Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients

Motamedi, 2003, Epilepsy and cognition, Epilepsy Behav, 4, S25, 10.1016/j.yebeh.2003.07.004 Aldenkamp, 2003, Newer antiepileptic drugs and cognitive issues, Epilepsia, 44, S21, 10.1046/j.1528-1157.44.s4.3.x Ortinski, 2004, Cognitive side effects of antiepileptic drugs, Epilepsy Behav, 5, S60, 10.1016/j.yebeh.2003.11.008 Masuda, 1998, Zonisamide: pharmacology and clinical efficacy in epilepsy, CNS Drug Rev, 4, 341, 10.1111/j.1527-3458.1998.tb00075.x Leppik, 1999, Zonisamide, Epilepsia, 40, S23, 10.1111/j.1528-1157.1999.tb00916.x Oommen, 1999, Zonisamide: a new antiepileptic drug, Clin Neuropharmacol, 22, 192 Leppik, 1993, Efficacy and safety of zonisamide: results of a multicenter study, Epilepsy Res, 14, 165, 10.1016/0920-1211(93)90021-X Tosches, 2006, Long-term efficacy and safety of monotherapy and adjunctive therapy with zonisamide, Epilepsy Behav, 8, 522, 10.1016/j.yebeh.2006.02.001 Ohtahara, 2007, Erratum to “Safety of zonisamide therapy: prospective follow-up survey”, Seizure, 16, 87, 10.1016/j.seizure.2006.01.005 Wilfong, 2005, Zonisamide monotherapy for epilepsy in children and young adults, Pediatr Neurol, 32, 77, 10.1016/j.pediatrneurol.2004.08.006 Kothare, 2006, Efficacy and safety of zonisamide monotherapy in a cohort of children with epilepsy, Pediatr Neurol, 34, 351, 10.1016/j.pediatrneurol.2005.10.007 Brodie, 2006, Zonisamide as adjunctive therapy for refractory partial seizures, Epilepsy Res, 68, S11, 10.1016/j.eplepsyres.2005.11.005 Leppik, 2006, Practical prescribing and long-term efficacy and safety of zonisamide, Epilepsy Res, 68, S17, 10.1016/j.eplepsyres.2005.11.006 Newmark, 2004, Zonisamide monotherapy in a multi-group clinic, Seizure, 13, 223, 10.1016/S1059-1311(03)00150-X Berent, 1987, Zonisamide (CI-912) and cognition: results from preliminary study, Epilepsia, 28, 61, 10.1111/j.1528-1157.1987.tb03624.x Wilensky, 1985, Zonisamide in epilepsy: a pilot study, Epilepsia, 26, 212, 10.1111/j.1528-1157.1985.tb05408.x Sapolsky, 2000, Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders, Arch Gen Psychiatry, 57, 925, 10.1001/archpsyc.57.10.925 Lutz, 2005, EpiTrack: tracking cognitive side effects of medication on attention and executive functions in patients with epilepsy, Epilepsy Behav, 7, 708, 10.1016/j.yebeh.2005.08.015 Williams, 1991 Wechsler, 1987 Reitan, 1993 Goodglass H, Kaplan E, Barresi B. Boston Diagnostic Aphasia Examination—Third Edition (BDAE-3). San Antonio, TX: Psychological Corp.; 2000. Beck, 1961, An inventory for measuring depression, Arch Gen Psychiatry, 4, 53, 10.1001/archpsyc.1961.01710120031004 Beck, 1990 Kockelmann, 2003, Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients, Epilepsy Res, 54, 171, 10.1016/S0920-1211(03)00078-0 Piazzini, 2001, The perception of memory failures in patients with epilepsy, Eur J Neurol, 8, 613, 10.1046/j.1468-1331.2001.00287.x Akaho, 1996, The effects of antiepileptic drugs on cognition in normal volunteers, Psychiatry Clin Neurosci, 50, 61, 10.1111/j.1440-1819.1996.tb01665.x Yamauchi, 2004, Efficacy of zonisamide: our experience, Seizure, 13, S41, 10.1016/j.seizure.2004.04.021 Sills, 2007, Pharmacokinetics and drug interactions with zonisamide, Epilepsia, 48, 435, 10.1111/j.1528-1167.2007.00983.x Lee, 2006, Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: a 1-year follow-up, Epilepsy Behav, 8, 736, 10.1016/j.yebeh.2006.03.006 Goodman, 1941 Dodrill, 1975, Effects of sulthiame upon intellectual, neuropsychological, and social functioning abilities among adult epileptics: comparison with diphenylhydantoin, Epilepsia, 16, 617, 10.1111/j.1528-1157.1975.tb04744.x Ueda, 2003, Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures, Brain Res Mol Brain Res, 116, 1, 10.1016/S0169-328X(03)00183-9 Petroff, 2001, Topiramate rapidly raises brain GABA in epilepsy patients, Epilepsia, 42, 543, 10.1046/j.1528-1157.2001.18800.x Aldenkamp, 2005, Behaviour, cognition and epilepsy, Acta Neurol Scand, 112, S19, 10.1111/j.1600-0404.2005.00523.x Berto, 2002, Quality of life in patients with epilepsy and impact of treatments, Pharmacoeconomics, 20, 1039, 10.2165/00019053-200220150-00002 Ketter, 1999, Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders, Neurology, 53, S53 McElroy, 2005, Open-label adjunctive zonisamide in the treatment of bipolar disorder: a prospective trial, J Clin Psychiatry, 66, 617, 10.4088/JCP.v66n0512